Inventor · disambiguated record
Cornelia Dorner-Ciossek
Also filed as: DORNER-CIOSSEK CORNELIA
25 granted patents·16 pending applications·142 citations·filing 2002–2025
95Inventor score
Files withBOEHRINGER INGELHEIM INT16FUCHS KLAUS6VITAE PHARMACEUTICALS INC4BOEHRINGER INGELHEIM PHARMA3GIOVANNINI RICCARDO3
Top patents by PatentIndex Score
41 records- 0193US7166599B2Trisubstituted pyrimidinesBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jan 23, 2007·54 cites·7 claims
- 0292US7238774B2Statine derivatives for the treatment of Alzheimer's disease IIIBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 3, 2007·13 cites·18 claims
- 0391US8981112B2Inhibitors of β-secretaseBOEHRINGER INGELHEIM INT·Filed 2013·Granted Mar 17, 2015·14 cites·17 claims
- 0488US8337845B2A-beta binding polypeptidesPARK JOHN E·Filed 2011·Granted Dec 25, 2012·18 cites·12 claims
- 0582US8648085B21, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disordersEICKMEIER CHRISTIAN·Filed 2008·Granted Feb 11, 2014·8 cites·9 claims
- 0682US8623879B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2009·Granted Jan 7, 2014·5 cites·39 claims
- 0779US10849907B2Imidazopyridine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 1, 2020·1 cites·49 claims
- 0877US9096603B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2013·Granted Aug 4, 2015·3 cites·4 claims
- 0977US6573276B2Muscarinic M1 agonist as an inhibitor of beta-amyloid (Aβ40 and Aβ42)-synthesisBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jun 3, 2003·10 cites·13 claims
- 1076US8623901B2Compounds for the treatment of CNS disordersGIOVANNINI RICCARDO·Filed 2010·Granted Jan 7, 2014·3 cites·22 claims
- 1175US9949975B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·1 cites·4 claims
- 1274US9079905B2Compounds for the treatment of CNS disordersFUCHS KLAUS·Filed 2009·Granted Jul 14, 2015·2 cites·4 claims
- 1374US8222264B2Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufactureFUCHS KLAUS·Filed 2008·Granted Jul 17, 2012·2 cites·18 claims
- 1473US8426607B2Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufactureFUCHS KLAUS·Filed 2009·Granted Apr 23, 2013·2 cites·16 claims
- 1572US9018391B2Inhibitors of beta-secretaseBUKHTIYAROV YURI·Filed 2013·Granted Apr 28, 2015·2 cites·38 claims
- 1672US8664388B2Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufactureFUCHS KLAUS·Filed 2012·Granted Mar 4, 2014·2 cites·1 claims
- 1771US11166958B24-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 9, 2021·0 cites·31 claims
- 1871US9526727B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·12 claims
- 1970US2021393644A14-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2068US8614308B2Nucleic acid molecules encoding A-beta binding polypeptidesPARK JOHN E·Filed 2012·Granted Dec 24, 2013·1 cites·3 claims
- 2167US2025345341A14-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 2263US2009325940A1Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses ThereofBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2362US2009099159A1Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide CompoundsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2461US11104670B24-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 31, 2021·0 cites·11 claims
- 2561US7534787B2Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compoundsBOEHRINGER INGELHEIM INT·Filed 2008·Granted May 19, 2009·0 cites·3 claims
- 2658US2018344734A1Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2756US9211330B2A-beta binding polypeptidesABLYNX NV·Filed 2013·Granted Dec 15, 2015·0 cites·5 claims
- 2856US7713961B2Substituted 1,2-ethylenediamines, methods for preparing them and uses thereofBOEHRINGER INGELHEIM INT·Filed 2006·Granted May 11, 2010·0 cites·27 claims
- 2954US7375220B2Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compoundsBOEHRINGER INGELHEIM VETMED·Filed 2005·Granted May 20, 2008·0 cites·4 claims
- 3052US2006160747A1Statine derivatives for the treatment of Alzheimer's disease IIBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3150US11155539B24-pyridinylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Oct 26, 2021·0 cites·12 claims
- 3248US2010204160A1Substituted 1,2-ethylenediamines, methods for preparing them and uses thereofBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3343US2010144681A1Compounds for the treatment of alzheimer's diseaseFUCHS KLAUS·Filed 2006·Application pending·0 cites
- 3443US2010168070A1Compounds for the treatment of alzheimer's diseaseHEINE NIKLAS·Filed 2006·Application pending·0 cites
- 3543US2009042867A1Compounds for the treatment of alzheimer's diseaseFUCHS KLAUS·Filed 2006·Application pending·0 cites
- 3641US2010298278A1Inhibitors of beta-secretase for the treatment of alzheimer's diseaseEICKMEIER CHRISTIAN·Filed 2006·Application pending·0 cites
- 3740US2015239849A1Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3839US2008293680A1Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease IIPETERS STEFAN·Filed 2006·Application pending·0 cites
- 3939US2006025345A1Substituted ethane-1,2-diamines for the treatment of Alzheimer's diseaseBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4036US2011212960A1New compounds for the treatment of cns disorderBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 4136US2003022251A1Gamma-secretase in vitro screening assayBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cornelia Dorner-Ciossek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →